Literature DB >> 8096235

Presentation of newly synthesized glycoproteins to CD4+ T lymphocytes. An analysis using influenza hemagglutinin transport mutants.

D J Kittlesen1, L R Brown, V L Braciale, J P Sambrook, M J Gething, T J Braciale.   

Abstract

Human lymphoblastoid cells transiently expressing the hemagglutinin (HA) glycoprotein of influenza virus are rapidly and efficiently recognized by CD4+ HA-specific T lymphocytes. This endogenous presentation pathway is sensitive to chloroquine and is therefore likely related to the classical class II major histocompatibility complex (MHC) exogenous pathway of antigen presentation. In this study we have examined a series of transport-defective HA mutants. We correlate the intracellular fate of the native antigen with its presentation characteristics. We have found that the native antigen must enter the secretory pathway since a cytosolic form is not presented. However, surface expression and normal trafficking through the Golgi apparatus are not required for efficient presentation. Instead, escape of native antigen from the endoplasmic reticulum appears to be both necessary and sufficient for gaining access to a compartment where antigen is processed and binds class II MHC molecules.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8096235      PMCID: PMC2190981          DOI: 10.1084/jem.177.4.1021

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  40 in total

Review 1.  Antigen presentation pathways to class I and class II MHC-restricted T lymphocytes.

Authors:  T J Braciale; L A Morrison; M T Sweetser; J Sambrook; M J Gething; V L Braciale
Journal:  Immunol Rev       Date:  1987-08       Impact factor: 12.988

2.  Structural studies of two ovalbumin glycopeptides in relation to the endo-beta-N-acetylglucosaminidase specificity.

Authors:  T Tai; K Yamashita; M Ogata-Arakawa; N Koide; T Muramatsu; S Iwashita; Y Inoue; A Kobata
Journal:  J Biol Chem       Date:  1975-11-10       Impact factor: 5.157

3.  Immunology. The ins and outs of antigen processing and presentation.

Authors:  R N Germain
Journal:  Nature       Date:  1986 Aug 21-27       Impact factor: 49.962

Review 4.  Assembly of asparagine-linked oligosaccharides.

Authors:  R Kornfeld; S Kornfeld
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

5.  3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes.

Authors:  P O Seglen; P B Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

6.  General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.

Authors:  M Mackett; G L Smith; B Moss
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

7.  Construction of influenza haemagglutinin genes that code for intracellular and secreted forms of the protein.

Authors:  M J Gething; J Sambrook
Journal:  Nature       Date:  1982-12-16       Impact factor: 49.962

8.  Mutations in the cytoplasmic domain of the influenza virus hemagglutinin affect different stages of intracellular transport.

Authors:  C Doyle; M G Roth; J Sambrook; M J Gething
Journal:  J Cell Biol       Date:  1985-03       Impact factor: 10.539

9.  Differences in antigen presentation to MHC class I-and class II-restricted influenza virus-specific cytolytic T lymphocyte clones.

Authors:  L A Morrison; A E Lukacher; V L Braciale; D P Fan; T J Braciale
Journal:  J Exp Med       Date:  1986-04-01       Impact factor: 14.307

10.  Disulfide bond formation during the folding of influenza virus hemagglutinin.

Authors:  M S Segal; J M Bye; J F Sambrook; M J Gething
Journal:  J Cell Biol       Date:  1992-07       Impact factor: 10.539

View more
  7 in total

Review 1.  Diversity in MHC class II antigen presentation.

Authors:  John H Robinson; Alexei A Delvig
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

2.  Presentation of a cytosolic antigen by major histocompatibility complex class II molecules requires a long-lived form of the antigen.

Authors:  M Guéguen; E O Long
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

3.  Ex vivo stimulation and expansion of both CD4(+) and CD8(+) T cells from peripheral blood mononuclear cells of human cytomegalovirus-seropositive blood donors by using a soluble recombinant chimeric protein, IE1-pp65.

Authors:  J Vaz-Santiago; J Lulé; P Rohrlich; C Jacquier; N Gibert; E Le Roy; D Betbeder; J L Davignon; C Davrinche
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

4.  Escape of human cytomegalovirus from HLA-DR-restricted CD4(+) T-cell response is mediated by repression of gamma interferon-induced class II transactivator expression.

Authors:  E Le Roy; A Mühlethaler-Mottet; C Davrinche; B Mach; J L Davignon
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

Review 5.  Virus-specific CD4+ T cells: ready for direct attack.

Authors:  Kevin N Heller; Cagan Gurer; Christian Münz
Journal:  J Exp Med       Date:  2006-03-20       Impact factor: 14.307

6.  A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides.

Authors:  E Mellins; P Cameron; M Amaya; S Goodman; D Pious; L Smith; B Arp
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

7.  Processing of a viral glycoprotein in the endoplasmic reticulum for class II presentation.

Authors:  S M Bartido; S Diment; C S Reiss
Journal:  Eur J Immunol       Date:  1995-08       Impact factor: 5.532

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.